Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The arginine deiminase system (ADS) is a metabolic pathway found in various bacteria, where it plays a crucial role in energy production, pH homeostasis, and adaptation to environmental stresses such as acidification. The system catabolizes L-arginine into citrulline and ammonia via arginine deiminase (ADI), ornithine carbamoyltransferase, and carbamate kinase. It generates ATP from ADP during anaerobic conditions and neutralizes acidic environments. ADS is considered a potential antimicrobial/antiparasitic drug target because it is absent in higher eukaryotes.
Inhibition of Arginine Deiminase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arginine Deiminase System (ADS).